| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 26.21% | UBS | $250 → $215 | Maintains | Buy |
| 10/24/2023 | 29.15% | Morgan Stanley | $235 → $220 | Maintains | Equal-Weight |
| 09/25/2023 | 22.69% | TD Cowen | $212 → $209 | Maintains | Market Perform |
| 09/22/2023 | 50.28% | Baird | $267 → $256 | Maintains | Outperform |
| 09/22/2023 | 32.08% | Guggenheim | $255 → $225 | Maintains | Buy |
| 09/22/2023 | 61.43% | Wells Fargo | $280 → $275 | Maintains | Overweight |
| 09/13/2023 | 24.45% | TD Cowen | → $212 | Initiates Coverage On | → Market Perform |
| 08/10/2023 | 46.76% | JP Morgan | $225 → $250 | Maintains | Overweight |
| 08/10/2023 | 43.82% | B of A Securities | $235 → $245 | Maintains | Buy |
| 07/11/2023 | 32.08% | Citigroup | $260 → $225 | Downgrades | Buy → Neutral |
| 07/10/2023 | 32.08% | Citigroup | $260 → $225 | Downgrades | Buy → Neutral |
| 05/15/2023 | 32.08% | Morgan Stanley | $230 → $225 | Maintains | Equal-Weight |
| 05/12/2023 | 49.69% | Credit Suisse | $260 → $255 | Maintains | Outperform |
| 05/12/2023 | 64.37% | Wells Fargo | $290 → $280 | Maintains | Overweight |
| 03/28/2023 | 19.17% | Jefferies | $233 → $203 | Maintains | Hold |
| 02/23/2023 | 52.63% | Credit Suisse | $280 → $260 | Maintains | Outperform |
| 02/23/2023 | 35.02% | Morgan Stanley | $241 → $230 | Maintains | Equal-Weight |
| 02/23/2023 | 52.63% | Citigroup | $280 → $260 | Maintains | Buy |
| 02/23/2023 | 49.69% | Guggenheim | → $255 | Upgrades | Neutral → Buy |
| 01/12/2023 | — | Jefferies | Downgrades | Buy → Hold | |
| 01/11/2023 | 67.3% | Baird | $275 → $285 | Maintains | Outperform |
| 11/03/2022 | 61.43% | JP Morgan | $280 → $275 | Maintains | Overweight |
| 11/03/2022 | 64.37% | Credit Suisse | $285 → $280 | Maintains | Outperform |
| 11/03/2022 | 41.47% | Morgan Stanley | $250 → $241 | Maintains | Equal-Weight |
| 09/30/2022 | 40.89% | Jefferies | → $240 | Upgrades | Hold → Buy |
| 08/25/2022 | 67.3% | Credit Suisse | → $285 | Initiates Coverage On | → Outperform |
| 08/16/2022 | 76.11% | Wells Fargo | $325 → $300 | Maintains | Overweight |
| 08/04/2022 | 46.76% | Morgan Stanley | $350 → $250 | Downgrades | Overweight → Equal-Weight |
| 07/14/2022 | 70.24% | Deutsche Bank | $350 → $290 | Maintains | Buy |
| 05/24/2022 | — | Guggenheim | Initiates Coverage On | → Neutral | |
| 05/05/2022 | 105.46% | Morgan Stanley | $430 → $350 | Maintains | Overweight |
| 05/05/2022 | 76.11% | Keybanc | $390 → $300 | Maintains | Overweight |
| 04/25/2022 | 90.78% | Wells Fargo | $390 → $325 | Maintains | Overweight |
| 04/25/2022 | 64.37% | Jefferies | $370 → $280 | Downgrades | Buy → Hold |
| 04/07/2022 | 121.31% | Stephens & Co. | → $377 | Initiates Coverage On | → Overweight |
| 02/17/2022 | 134.81% | Citigroup | → $400 | Upgrades | Neutral → Buy |
| 02/17/2022 | 152.42% | Morgan Stanley | $465 → $430 | Maintains | Overweight |
| 02/17/2022 | 128.94% | Keybanc | $450 → $390 | Maintains | Overweight |
| 11/04/2021 | 172.97% | Morgan Stanley | $480 → $465 | Maintains | Overweight |
| 08/17/2021 | 172.97% | UBS | $390 → $465 | Maintains | Buy |
| 07/20/2021 | 126.01% | Credit Suisse | $352 → $385 | Maintains | Neutral |
| 05/28/2021 | 108.39% | Citigroup | $350 → $355 | Maintains | Neutral |
| 05/28/2021 | 106.63% | Credit Suisse | $342 → $352 | Maintains | Neutral |
| 05/28/2021 | 128.94% | JP Morgan | $375 → $390 | Maintains | Overweight |
| 05/25/2021 | 116.61% | Truist Securities | $324 → $369 | Maintains | Buy |
| 05/14/2021 | 111.33% | Keybanc | $340 → $360 | Maintains | Overweight |
| 02/22/2021 | 105.46% | Morgan Stanley | $280 → $350 | Maintains | Overweight |
| 02/19/2021 | 105.46% | Morgan Stanley | $280 → $350 | Maintains | Overweight |
| 02/18/2021 | 90.2% | Truist Securities | $256 → $324 | Maintains | Buy |
| 02/18/2021 | 96.07% | Deutsche Bank | $250 → $334 | Maintains | Buy |
| 12/16/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
| 11/24/2020 | 50.28% | Keybanc | $233 → $256 | Maintains | Overweight |
| 10/30/2020 | 52.63% | Morgan Stanley | $245 → $260 | Maintains | Overweight |
| 09/14/2020 | 37.95% | Argus Research | $190 → $235 | Maintains | Buy |
| 09/10/2020 | 49.1% | Jefferies | $213 → $254 | Upgrades | Hold → Buy |
| 08/18/2020 | 36.78% | Keybanc | $186 → $233 | Maintains | Overweight |
| 08/06/2020 | 43.82% | Morgan Stanley | $175 → $245 | Maintains | Overweight |
| 08/06/2020 | 49.69% | Citigroup | $190 → $255 | Maintains | Buy |
| 07/01/2020 | 12.71% | B of A Securities | → $192 | Upgrades | Neutral → Buy |
| 05/13/2020 | 17.41% | UBS | $177 → $200 | Upgrades | Neutral → Buy |
| 05/12/2020 | 2.14% | Deutsche Bank | $190 → $174 | Maintains | Buy |
| 05/08/2020 | 5.66% | JP Morgan | $160 → $180 | Maintains | Overweight |
| 05/08/2020 | 13.88% | SunTrust Robinson Humphrey | $130 → $194 | Maintains | Buy |
| 05/08/2020 | -6.66% | Credit Suisse | $162 → $159 | Maintains | Neutral |
| 05/08/2020 | 2.73% | Morgan Stanley | $152 → $175 | Maintains | Overweight |
| 05/08/2020 | 11.54% | Citigroup | $165 → $190 | Maintains | Buy |
| 04/21/2020 | — | Jefferies | Downgrades | Buy → Hold | |
| 04/09/2020 | -3.14% | Citigroup | $200 → $165 | Maintains | Buy |
| 04/06/2020 | -23.69% | SunTrust Robinson Humphrey | $124 → $130 | Maintains | Buy |
| 03/30/2020 | -14.88% | Wells Fargo | $200 → $145 | Maintains | Overweight |
| 03/27/2020 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 03/26/2020 | -9.6% | Barclays | $170 → $154 | Maintains | Equal-Weight |
| 03/23/2020 | -18.4% | Jefferies | $200 → $139 | Maintains | Buy |
| 03/17/2020 | -27.21% | SunTrust Robinson Humphrey | $188 → $124 | Maintains | Buy |
| 03/02/2020 | 11.54% | Deutsche Bank | → $190 | Initiates Coverage On | → Buy |
| 02/18/2020 | 19.17% | Wolfe Research | $169 → $203 | Upgrades | Peer Perform → Outperform |
| 02/12/2020 | 8.6% | Baird | $165 → $185 | Maintains | Outperform |
| 02/12/2020 | 3.32% | Morgan Stanley | $156 → $176 | Maintains | Equal-Weight |
| 02/11/2020 | 5.66% | CFRA | $165 → $180 | Maintains | Strong Buy |
| 01/10/2020 | -0.21% | Goldman Sachs | $143 → $170 | Upgrades | Neutral → Buy |
| 01/08/2020 | 5.66% | Wells Fargo | → $180 | Initiates Coverage On | → Overweight |
| 01/07/2020 | 8.6% | Citigroup | → $185 | Initiates Coverage On | → Buy |
| 12/17/2019 | -3.14% | Baird | $160 → $165 | Maintains | Outperform |
| 12/09/2019 | -4.9% | Keybanc | $151 → $162 | Maintains | Overweight |
| 11/07/2019 | -14.88% | UBS | $147 → $145 | Maintains | Neutral |
| 10/18/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 09/16/2019 | -4.9% | SunTrust Robinson Humphrey | $156 → $162 | Maintains | Buy |
| 03/18/2019 | -14.88% | Barclays | $135 → $145 | Maintains | Equal-Weight |
| 03/11/2019 | -11.36% | Keybanc | $140 → $151 | Maintains | Overweight |
| 12/03/2018 | -20.16% | Morgan Stanley | $112 → $136 | Maintains | Equal-Weight |
What is the target price for Charles River (CRL)?
The latest price target for Charles River (NYSE: CRL) was reported by UBS on November 9, 2023. The analyst firm set a price target for $215.00 expecting CRL to rise to within 12 months (a possible 26.21% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Charles River (CRL)?
The latest analyst rating for Charles River (NYSE: CRL) was provided by UBS, and Charles River maintained their buy rating.
When is the next analyst rating going to be posted or updated for Charles River (CRL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Charles River, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Charles River was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Charles River (CRL) correct?
While ratings are subjective and will change, the latest Charles River (CRL) rating was a maintained with a price target of $250.00 to $215.00. The current price Charles River (CRL) is trading at is $170.35, which is out of the analyst's predicted range.